During Tuesday's "Lightning Round" segment of Mad Money, one caller asked Jim Cramer about Aurinia Pharmaceuticals (AUPH) : "They should be doing better. I want to be careful with that stock," he responded.
In this daily bar chart of AUPH, below, we can see three rally failures in the past two months. The slope of the 200-day moving average line is negative.
The daily On-Balance-Volume (OBV) line is bearish and the Moving Average Convergence Divergence (MACD) oscillator has spent much of the past 12 months below the zero line.
In this weekly Japanese candlestick chart of AUPH, below, we can see that prices have been in a downward trend since early 2020. The weekly OBV line shows improvement in recent months and the MACD oscillator is bearish.
In this daily Point and Figure chart of AUPH, below, we can see a downside price target of $12.
In this weekly Point and Figure chart of AUPH, below, we can see a potential $8 price target.
Bottom line strategy: The charts of AUPH are weak and pointed lower. Avoid the long side.
